Published date: 2 June 2021

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 31 March 2021, 12am

Contract summary

Industry

  • Medical equipments, pharmaceuticals and personal care products - 33000000

Location of contract

Any region

Value of contract

£0 to £309,174

Procurement reference

tender_274842/968459

Published date

2 June 2021

Closing date

31 March 2021

Closing time

12am

Contract start date

1 April 2021

Contract end date

31 March 2023

Contract type

Supply contract

Procedure type

Single tender action (below threshold)

A direct contract with a single supplier, without competition.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Public Health England (PHE) is responsible for the provision of public health stocks of exotic antivenoms for NHS emergency use in the UK. The antivenoms are used in the event of someone being bitten or stung by an exotic venomous animal.

This requirement is to source 24 different highly specialist exotic antivenoms from national and international Suppliers.

As there are 11 different suppliers for this purchase, each of whom supplies a very small volume of antivenoms, Public Health England will communicate with suppliers and place orders following an exchange of e-mails with the supplier to confirm price per dose, shelf life and delivery timescales. The UK hub sites based across the country are required to hold specified minimum volume on likely treatment dosage. This allows delivery to be made within 5 hours (best endeavours) from when the request is received to any hospital location within the UK.

This contract is being awarded under Reg 32(2)(b)(ii). The total contract value specified per supplier cannot be confirmed, as this is dependant on different expiry date of stocks held across various sites across UK. Additionally, the selection of each antivenom will be based on the opinion of the Advisory Group.

More information

Attachments

Award information

Awarded date

31 March 2021

Contract start date

1 April 2021

Contract end date

31 March 2023

Total value of contract

£309,173.57

This contract was awarded to 11 suppliers.

South African Vaccine Producers (SAVP)

Address

2131 Sandringham, South Africa

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

Instituto Clodomiro Picado Universidad de Costa Rica

Address

Costa Rica

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

MicroPharm Ltd

Address

Carmarthenshire, UK

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

National Antivenom and Vaccine Production Centre

Address

Saudi Arabia

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

Razi Vaccine & Serum Research Institute

Address

Kraj, Iran

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

Haffkine BioPharmaceutical Corp Ltd

Address

Mumbai, India

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

Queen Saovabha Memorial Institute

Address

Bangkok, Thailand

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

Centers for Disease Control

Address

Taipei City, Taiwan

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

Seqirus

Address

Victoria, Australia

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

Instituto Butantan

Address

Av. Vital, Brazil

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

Serb-labo

Address

Av. Louise, Belgium

Reference

No reference - other

Supplier is SME?

Yes

Supplier is VCSE?

No

About the buyer

Address

Public Health England, 61 Colindale Avenue
London
NW9 5EQ
England

Email

nirula.sethi@phe.gov.uk